Boeck C.Multiple benign sarkoid of the skin. J Cutan Genitourinary Dis1899; 17: 543-550.
2.
Scadding JG and Mitchell DNSarcoidosis. London: Chapman and Hall Ltd; 1985.
3.
Hosoda Y., Yamaguchi M., Hiraga Y.Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us?Clinics in Chest Medicine1997; 18: 681-694.
4.
Rybicki BA, Iannuzzi MC, Rybicki BA, Iannuzzi MCEpidemiology of sarcoidosis: recent advances and future prospects . Semin2007; 28: 22-35.
5.
Iannuzzi MCAdvances in the genetics of sarcoidosis. Proc Am Thorac Soc2007; 4: 457-460.
6.
Valeyre D., Uzunhan Y., Bouvry D., Naccache JM, Nunes H.Up-to-date in pulmonary and extrapulmonary sarcoidosis. Acta Clin Belg2008; 63: 408-413.
7.
Baughman RP, Teirstein A., Judson MA, Rossman M., Yeager H., Jr, Bresnitz E., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med2001; 164: 1885-1889.
8.
Wilsher MLSeasonal clustering of sarcoidosis presenting with erythema nodosum . Eur Respir J1998; 12: 1197-1199.
9.
Demirkok SS, Basaranoglu M., Akbilgic O.Seasonal variation of the onset of presentations in stage 1 sarcoidosis . Int J Clin Pract2006; 60: 1443-1450.
10.
Demirkok SS , Basaranoglu M., Coker E., Karayel T.Seasonality of the onset of symptoms, tuberculin test anergy and kveim positive reaction in a large cohort of patients with sarcoidosis. Respirology2007; 12: 591-593.
11.
Barnard J., Rose C., Newman L., Canner M., Martyny J., McCammon C., et al. Job and industry classifications associated with sarcoidosis in a case-control etiologic study of sarcoidosis (access). J Occup Environ Med2005; 47: 226-234.
12.
Brown ST, Brett I., Almenoff PL, Lesser M., Terrin M., Teirstein AS, et al. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects.[see comment] . Chest2003; 123: 413-417.
13.
Vokurka M., Lecossier D., du Bois RM, Wallaert B., Kambouchner M., Tazi A., et al. Absence of DNA from mycobacteria of the m. Tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med1997; 156: 1000-1003.
14.
Wilsher ML, Menzies RE, Croxson MCMycobacterium tuberculosis DNA in tissues affected by sarcoidosis . Thorax1998; 53: 871-874.
15.
Yasuhara T. , Tada R., Nakano Y., Tei M., Mochida C., Kamei M., et al. The presence of propionibacterium spp. In the vitreous fluid of uveitis patients with sarcoidosis . Acta Ophthalmol Scand2005; 83: 364-369.
16.
du Bois RM, Goh N., McGrath D., Cullinan P.Is there a role for microorganisms in the pathogenesis of sarcoidosis?J Int Med2003; 253: 4-17.
17.
Gupta D., Agarwal R., Aggarwal AN, Jindal SKMolecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis . Eur Respir J2007; 30: 508-516.
18.
Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (access). Am J Respir Crit Care Med2001; 164: 2085-2091.
19.
Grunewald J. , Grunewald J.Genetics of sarcoidosis. Curr Opin Pulmon Med2008; 14: 434-439.
20.
Rybicki BA, Iannuzzi MCEpidemiology of sarcoidosis: Recent advances and future prospects . Semin Respir Crit Care Med2007; 28: 22-35.
21.
Spagnolo P. , du Bois RM, Spagnolo P., du Bois RMGenetics of sarcoidosis. Clin Dermatol2007;25: 242-249.
22.
Rossman MD, Thompson B., Frederick M., Iannuzzi MC, Rybicki BA, Pander JP, et al. Hla and environmental interactions in sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases2008; 25: 125-132.
23.
Izbicki G., Chavko R., Banauch GI, Weiden MD, Berger KI, Aldrich TK, et al. World trade center ‘‘Sarcoid-like’’ Granulomatous pulmonary disease in New York city fire department rescue workers.[see comment]. Chest2007; 131: 1414-1423.
24.
Prezant DJ, Dhala A., Goldstein A., Janus D., Ortiz F., Aldrich TK, et al. The incidence, prevalence, and severity of sarcoidosis in New York city firefighters. Chest1999; 116: 1183-1193.
25.
Hill TA, Lightman S., Pantelidis P., Abdallah A., Spagnolo P., du Bois RMIntracellular cytokine profiles and t cell activation in pulmonary sarcoidosis . Cytokine2008; 42: 289-292.
26.
Zissel G., Prasse A., Muller-Quernheim J., Zissel G., Prasse A., Muller-Quernheim J.Sarcoidosis-immunopathogenetic concepts. Semin2007; 28: 3-14.
27.
Fehervari Z. , Sakaguchi S., Fehervari Z., Sakaguchi S.Cd4+ tregs and immune control. J Clin Invest2004; 114: 1209-1217.
28.
Shigehara K. , Shijubo N., Ohmichi M., Takahashi R., Kon S., Okamura H., et al. Il-12 and il-18 are increased and stimulate ifn-gamma production in sarcoid lungs. J Immunol2001; 166: 642-649.
29.
Grunewald J. , Eklund A., Grunewald J., Eklund A.Role of cd4+ t cells in sarcoidosis. Proc Am Thorac Soc2007; 4: 461-464.
30.
Grunewald J. , Wahlstrom J., Berlin M., Wigzell H., Eklund A., Olerup O.Lung restricted t cell receptor av2s3+ cd4+ t cell expansions in sarcoidosis patients with a shared hla-drbeta chain conformation . Thorax2002; 57: 348-352.
31.
Esin S., Batoni G., Saruhan-Direskeneli G., Harris RA, Grunewald J., Pardini M., et al. In vitro expansion of t-cell-receptor valpha2.3(+) cd4(+) t lymphocytes in hla-dr17(3), dq2(+) individuals upon stimulation with mycobacterium tuberculosis. Infect Immun1999; 67: 3800-3809.
32.
Chen ES, Wahlstrom J., Song Z., Willett MH, Wiken M., Yung RC, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol2008; 181: 8784-8796.
33.
Boyton RJ, Altmann DM, Wright A., Kon OM, Boyton RJ, Altmann DM, et al. Pulmonary infection with cryptococcus neoformans in the face of underlying sarcoidosis. Respiration2007 ; 74: 462-466.
34.
Mayock RL, Bertrand P., Morrison CE, Scott JHManifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med1963; 35: 67-89.
35.
Reich JM, Johnson RECourse and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years. Am J Med1985; 78: 61-67.
36.
Sipahi Demirkok S., Basaranoglu M., Dervis E., Bal M., Karayel T.Analysis of 87 patients with lofgren’s syndrome and the pattern of seasonality of subacute sarcoidosis. Respirology2006; 11: 456-461.
37.
Michielsen HJ, Peros-Golubicic T., Drent M., De Vries J.Relationship between symptoms and quality of life in a sarcoidosis population. Respiration2007; 74: 401-405.
38.
Sharma OPFatigue and sarcoidosis [comment]. Eur Respir J1999; 13: 713-714.
39.
Michielsen HJ, Drent M., Peros-Golubicic T., De Vries J.Fatigue is associated with quality of life in sarcoidosis patients. Chest2006; 130: 989-994.
40.
Drent M., Wirnsberger RM, de Vries J., van Dieijen-Visser MP, Wouters EF, Schols AMAssociation of fatigue with an acute phase response in sarcoidosis [see comment] . Eur Respir J1999; 13: 718-722.
41.
Lynch JP, 3rd, Ma YL, Koss MN, White ESPulmonary sarcoidosis . Semin2007; 28: 53-74.
42.
Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MAHealth-related quality of life of persons with sarcoidosis. Chest2004; 125: 997-1004.
43.
Scadding J.Prognosis of intrathoracic sarcoidosis in England: A review of 136 cases after five years’ observation. British medical journal1961; 2: 1165-1172.
44.
Halme M., Piilonen A., Taskinen E.Comparison of endobronchial and transbronchial biopsies with high-resolution ct (hrcit) in the diagnosis of sarcoidosis. APMIS2001; 109: 289-294.
45.
Akira M., Kozuka T., Inoue Y., Sakatani M.Long-term follow-up ct scan evaluation in patients with pulmonary sarcoidosis . Chest2005; 127: 185-191.
Brauner MW, Grenier P., Mompoint D., Lenoir S., de Cremoux H.Pulmonary sarcoidosis: evaluation with high-resolution ct. Radiology1989; 172: 467-471.
48.
Muller NL, Mawson JB, Mathieson JR, Abboud R., Ostrow DN, Champion P.Sarcoidosis: correlation of extent of disease at ct with clinical, functional, and radiographic findings. Radiology1989; 171: 613-618.
49.
Hansell DM, Milne DG, Wilsher ML, Wells AUPulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section ct. Radiology1998; 209: 697-704.
50.
Drent M., De Vries J., Lenters M., Lamers RJS, Rothkranz-Kos S., Wouters EFM, van Dieijen-Visser MP, Verschakelen JASarcoidosis: assessment of disease severity using HRCT. Eur Radiol2003; 13: 2462-2471.
51.
Winterbauer RH, Hutchinson JFUse of pulmonary function tests in the management of sarcoidosis. Chest1980 ; 78: 640-647.
52.
Harrison BD , Shaylor JM, Stokes TC, Wilkes ARAirflow limitation in sarcoidosis-a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med1991; 85: 59-64.
53.
Bechtel JJ, Starr T., 3rd, Dantzker DR, Bower JSAirway hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis1981; 124: 759-761.
54.
Baughman RP , Sparkman BK, Lower EESix-minute walk test and health status assessment in sarcoidosis. Chest2007; 132: 207-213.
55.
Battesti JP , Georges R., Basset F., Saumon G.Chronic cor pulmonale in pulmonary sarcoidosis . Thorax1978; 33: 76-84.
56.
Neville E., Walker AN, James DGPrognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med1983; 52: 525-533.
57.
Handa T., Nagai S., Miki S., Fushimi Y., Ohta K., Mishima M., et al. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest2006; 129: 1246-1252.
58.
Shorr AF, Davies DB, Nathan SDPredicting mortality in patients with sarcoidosis awaiting lung transplantation . Chest2003; 124: 922-928.
59.
Shorr AF, Helman DL, Davies DB, Nathan SDPulmonary hypertension in advanced sarcoidosis: Epidemiology and clinical characteristics. Eur Respir J2005; 25: 783-788.
60.
Nunes H., Humbert M., Capron F., Brauner M., Sitbon O., Battesti JP, et al. Pulmonary hypertension associated with sarcoidosis: Mechanisms, haemodynamics and prognosis. Thorax2006; 61: 68-74.
61.
Sulica R., Teirstein AS, Kakarla S., Nemani N., Behnegar A., Padilla ML, et al. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest2005; 128: 1483-1489.
62.
Arcasoy SM, Christie JD, Ferrari VA, Sutton MSJ, Zisman DA, Blumenthal NP, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med2003; 167: 735-740.
Ng CS, Wells AU, Padley SPA ct sign of chronic pulmonary arterial hypertension: The ratio of main pulmonary artery to aortic diameter. J Thorac Imaging1999; 14: 270-278.
65.
Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H., Jr.Defining organ involvement in sarcoidosis: The access proposed instrument. Access research group.A case control etiologic study of sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases1999; 16: 75-86.
66.
Society ATStatement on sarcoidosis. Am J Respir Crit Care Med1999; 160: 736-755.
67.
Wilsher ML, Hopkins R., Young LM, Cornere M., West T.Characteristics of sarcoidosis in maori and pacific islanders. Am J Respir Crit Care Med2005; 171(supplement): A864.
68.
Ohara K., Judson M., Baughman R.Clinical aspects of ocular sarcoidosis. Eur Respir Monogr2005; 32: 188-209.
Silverman KJ , Hutchins GM, Bulkley BHCardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis . Circulation1978; 58: 1204-1211.
71.
Uemura A., Morimoto S., Hiramitsu S., Kato Y., Ito T., Hishida H.Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J1999; 138: 299-302.
72.
Yamagishi H. , Shirai N., Takagi M., Yoshiyama M., Akioka K., Takeuchi K., et al. Identification of cardiac sarcoidosis with (13)n-nh(3)/(18)f-fdg pet [see comment]. J Nucl Med2003; 44: 1030-1036.
73.
Sharma OPNeurosarcoidosis: a personal perspective based on the study of 37 patients . Chest1997; 112: 220-228.
74.
Roethe RA, Fuller PB, Byrd RB, Hafermann DRTransbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis. Chest1980; 77: 400-402.
75.
Poe RH, Israel RH, Utell MJ, Hall WJProbability of a positive transbronchial lung biopsy result in sarcoidosis . Arch Intern Med1979; 139: 761-763.
76.
de Boer S., Milne DG, Zeng I., Wilsher MLDoes ct scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?Thorax2009; 64: 436-439.
77.
Shorr AF, Torrington KG, Hnatiuk OWEndobronchial biopsy for sarcoidosis: a prospective study. Chest2001; 120: 109-114.
78.
Wildi SM, Judson MA, Fraig M., Fickling WE, Schmulewitz N., Varadarajulu S., et al. Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think?Thorax2004 ; 59: 794-799.
79.
Wong M., Yasufuku K., Nakajima T., Herth FJF, Sekine Y., Shibuya K., et al. Endobronchial ultrasound: New insight for the diagnosis of sarcoidosis [see comment]. Eur Respir J2007; 29: 1182-1186.
80.
Garwood S., Judson MA, Silvestri G., Hoda R., Fraig M., Doelken P.Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis [see comment] . Chest2007; 132: 1298-1304.
81.
Annema JT, Veselic M., Rabe KFEndoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis [see comment]. Eur Respir J2005; 25: 405-409.
82.
Biller H., Zissel G., Ruprecht B., Nauck M., Busse Grawitz A., Muller-Quernheim J.Genotype-corrected reference values for serum angiotensin-converting enzyme . Eur Respir J2006; 28: 1085-1090.
83.
Lieberman J. , Schleissner LA, Nosal A., Sastre A., Mishkin FSClinical correlations of serum angiotensin-converting enzyme (ace) in sarcoidosis. A longitudinal study of serum ace, 67gallium scans, chest roentgenograms, and pulmonary function. Chest1983; 84: 522-528.
84.
Costabel U.Cd4/cd8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis? [comment]. Eur Respir J1997; 10: 2699-2700.
85.
Paramothayan NS, Lasserson TJ, Jones P.Corticosteroids for pulmonary sarcoidosis . Cochrane Database of Systematic Reviews2009; 1.
86.
Wells AU, Hirani N., British Thoracic SocietyInterstitial Lung DiseaseGuideline GroupBTSSoCC, Thoracic Society of A, New Zealand Thoracic S, Irish Thoracic S. Interstitial lung disease guideline: The British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society. Thorax2008; 63(suppl 5): v1-58.
87.
Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK, et al. British thoracic society sarcoidosis study: effects of long term corticosteroid treatment [see comment]. Thorax1996; 51: 238-247.
88.
Selroos O., Lofroos AB, Pietinalho A., Niemisto M., Riska H.Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis . Sarcoidosis1994; 11: 126-131.
89.
Gottlieb JE , Israel HL, Steiner R Mea.Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest11997; 111: 623-631.
90.
Alberts C., van der Mark TW, Jansen HMInhaled budesonide in pulmonary sarcoidosis: A double blind, placebo controlled study. Dutch study group on pulmonary sarcoidosis. Eur Respir J1995; 8: 682-688.
91.
Dev S., McCallum RM, Jaffe GJMethotrexate treatment for sarcoid-associated panuveitis. Ophthalmology1999; 106: 111-118.
92.
Lower EE, Baughman RPProlonged use of methotrexate for sarcoidosis. Arch Intern Med1995; 155: 846-851.
93.
Smith JR, Rosenbaum JTA role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol2001 ; 85: 1220-1224.
94.
Vucinic VM, Vucinic VMWhat is the future of methotrexate in sarcoidosis? A study and review . Curr Opin Pulmon Med2002; 8: 470-476.
95.
Lewis SJ, Ainslie GM, Bateman EDEfficacy of azathioprine as second-line treatment in pulmonary sarcoidosis . Sarcoidosis Vasculitis and Diffuse Lung Diseases1999; 16: 87-92.
96.
Muller-Quernheim J., Kienast K., Held M., Pfeifer S., Costabel U.Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen [see comment] . Eur Respir J1999; 14: 1117-1122.
97.
Baughman RP , Winget DB, Lower EEMethotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial . Sarcoidosis Vasculitis and Diffuse Lung Diseases2000; 17: 60-66.
98.
Anonymous.Chloroquine in the treatment of sarcoidosis. A report from the research committee of the British tuberculosis association. Tubercle1967; 48: 257-272.
99.
Baltzan M., Mehta S., Kirkham TH, Cosio MGRandomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis . Am J Respir Crit Care Med1999 ; 160: 192-197.
100.
Doty JD, Mazur JE, Judson MA, Doty JD, Mazur JE, Judson MATreatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest2003; 124: 2023-2026.
101.
Israel HL, McComb BLChlorambucil treatment of sarcoidosis. Sarcoidosis1991; 8: 35-41.
102.
Kataria YPChlorambucil in sarcoidosis. Chest1980; 78: 36-43.
103.
Paramothayan S., Lasserson T., Walters EHImmunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.[update in cochrane database syst rev . 2006;3:Cd003536; pmid: 16856012]. Cochrane Database of Systematic Reviews2003: CD003536.
104.
Wyser CP, van Schalkwyk EM, Alheit B., Bardin PG, Joubert JRTreatment of progressive pulmonary sarcoidosis with cyclosporin a. A randomized controlled trial [see comment]. Am J Respir Crit Care Med1997; 156: 1371-1376.
105.
York EL, Kovithavongs T., Man SF, Rebuck AS, Sproule BJCyclosporine and chronic sarcoidosis. Chest1990; 98: 1026-1029.
106.
Zabel P., Entzian P., Dalhoff K., Schlaak M.Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med1997; 155: 1665-1669.
107.
Baughman RP , Judson MA, Teirstein AS, Moller DR, Lower EE, Baughman RP, et al. Thalidomide for chronic sarcoidosis . Chest2002; 122: 227-232.
108.
Barnabe C. , McMeekin J., Howarth A., Martin L., Barnabe C., McMeekin J., et al. Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol2008; 35: 1686-1687.
109.
Baughman RP , Bradley DA, Lower EEInfliximab in chronic ocular inflammation . Int J Clin Pharmacol Therapeut2005; 43: 7-11.
110.
Hoitsma E., Faber CG, van Santen-Hoeufft M., De Vries J., Reulen JP, Drent M., et al. Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoidosis Vasculitis and Diffuse Lung Diseases2006; 23: 73-77.
111.
Moravan M., Segal BM, Moravan M., Segal BMTreatment of CNS sarcoidosis with infliximab and mycophenolate mofetil . Neurology2009; 72: 337-340.
112.
Pritchard C. , Nadarajah K.Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients . Ann Rheumatic Dis2004; 63: 318-320.
113.
Saleh S., Ghodsian S., Yakimova V., Henderson J., Sharma OP, Saleh S., et al. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med2006; 100: 2053-2059.
114.
Stagaki E. , Mountford WK, Lackland DT, Judson MA, Stagaki E., Mountford WK, et al. The treatment of lupus pernio: Results of 116 treatment courses in 54 patients . Chest2009; 135: 468-476.
115.
Baughman RP , Drent M., Kavuru M., Judson MA, Costabel U., du Bois R., et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med2006; 174: 795-802.
116.
Judson MA, Baughman RP, Costabel U., Flavin S., Lo KH, Kavuru MS, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J2008 ; 31: 1189-1196.
117.
Caviglia R. , Boskoski I., Cicala M., Caviglia R., Boskoski I., Cicala M.Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues . Expert Opin Drug Saf2008; 7: 617-632.
Shorr AF, Helman DL, Davies DB, Nathan SD, Shorr AF, Helman DL, et al. Sarcoidosis, race, and short-term outcomes following lung transplantation . Chest2004; 125: 990-996.
120.
Barnett CF , Bonura EJ, Nathan SD, Ahmad S., Shlobin OA, Osei K., et al. Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience [see comment]. Chest2009; 135: 1455-1461.
121.
Hamilton-Craig CR, Slaughter R., McNeil K., Kermeen F., Walters DLImprovement after angioplasty and stenting of pulmonary arteries due to sarcoid mediastinal fibrosis. Heart, Lung and Circulation2009 ; 18: 222-225.